Skip to main content
. 2022 Apr 21;18:100390. doi: 10.1016/j.lanepe.2022.100390

Table 2.

Mean scores per group per assessment and results of the linear mixed model analyses on primary and secondary outcome measures for the total group.

Baseline (t0)
2 weeks follow-up (t1)
3-months follow-up (t2)
N Mean (SD) N Mean (SD) N Mean (SD) Estimated difference in change between T0 and T2 (90% CI) P-value two-way interaction
Patient activation (PAM) 0·56
 Intervention 65 55·6 (11·5) 65 55·1 (12·5) 59 56·4 (11·7) 1·8 (-1·0 to 4·7)
 Control 68 55·1 (11·5) 68 54·7 (9·8) 61 54·7 (11·6)
General self-efficacy (GSE) 0·23
 Intervention 69 29·5 (5·5) 67 29·5 (5·4) 60 30·0 (5·7) 1·0 (-0·2 to 2·2)
 Control 69 31·1 (4·5) 68 29·9 (4·6) 62 30·6 (4·3)
HRQOL (EORTC-QLQ-C15-PAL)
Global quality of life 0·69
 Intervention 69 73·9 (18·8) 67 69·9 (18·2) 60 70·3 (21·3) -2·6 (-7·5 to 2·4)
 Control 69 73·4 (18·4) 68 70·6 (22·5) 62 72·6 (18·9)
Physical functioning 0·23
 Intervention 69 88·1 (14·4) 67 88·2 (13·4) 60 87·0 (15·2) -0·8 (-4·3 to 2·6)
 Control 69 90·3 (16·3) 68 87·6 (18·5) 62 88·7 (18·4)
Emotional functioning 0·32
 Intervention 69 71·7 (24·3) 67 74·9 (22·4) 60 71·9 (26·3) 4·6 (-1·0 to 10·1)
 Control 69 81·2 (21·0) 68 81·1 (20·7) 62 77·7 (22·2)
Fatigue 0·27
 Intervention 69 45·4 (28·0) 67 42·0 (24·7) 60 44·4 (28·6) -3·2 (-9·8 to 3·4)
 Control 69 35·7 (25·6) 68 39·0 (30·1) 62 37·9 (27·7)
Pain 0·54
 Intervention 69 27·5 (28·1) 67 27·9 (24·3) 60 29·4 (27·3) 2·6 (-3·7 to 8·9)
 Control 69 22·9 (25·3) 68 25·2 (26·5) 62 24·2 (27·1)
Dyspnea 0·32
 Intervention 69 19·3 (23·2) 67 22·4 (25·5) 60 21·1 (25·3) 4·7(-1·3 to 10·6)
 Control 69 19·3 (25·8) 68 17·6 (26·7) 62 15·6 (25·4)
Insomnia 0·91
 Intervention 69 33·3 (31·8) 67 31·3 (30·6) 60 32·2 (28·1) 0·4 (-7·1 to 7·9)
 Control 69 29·5 (30·0) 68 28·9 (28·7) 62 25·8 (29·8)
Appetite loss 0·66
 Intervention 69 22·2 (30·6) 67 19·4 (30·2) 60 21·7 (29·3) -2·3 (-10·2 to 5·6)
 Control 69 18·4 (26·5) 68 20·1 (29·4) 62 22·0 (29·5)
Nausea 0·68
 Intervention 69 18·8 (30·0) 67 13·9 (24·0) 60 20·6 (28·2) 2·8 (-5·6 to 11·2)
 Control 69 18·8 (24·6) 68 15·7 (27·3) 62 18·3 (26·8)
Constipation 0·48
 Intervention 69 24·2 (27·3) 67 20·9 (25·8) 60 22·2 (26·5) -5·8 (-14·0 to 2·3)
 Control 69 18·8 (21·8) 68 19·1 (27·8) 62 21·5 (29·0)